Physician profile
Mohammad Abureesh
NPI 1770074510
$4,796.16
in general payments reported to CMS, 2019-2025
6 companies · $3,349 in 2025
The $3,349 reported for 2025 was more than what 98% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $848 · 2024: $599 · 2025: $3,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,291 · Grant: $708 · Food and Beverage: $698 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,290.53 |
| Grant | $708.17 |
| Food and Beverage | $698.46 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $3,245.37 | 2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Cook Incorporated | $708.17 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $393.49 | 2024 | |
| Boston Scientific Corporation | $246.32 | 2023-2024 | Acquire, Axios, Wallflex Duodenal |
| Madrigal Pharmaceuticals | $103.81 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $99.00 | 2024 | Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Abureesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.